ATE134990T1 - Neues verfahren zur darstellung von formoterol und vewandten verbindungen - Google Patents

Neues verfahren zur darstellung von formoterol und vewandten verbindungen

Info

Publication number
ATE134990T1
ATE134990T1 AT91917624T AT91917624T ATE134990T1 AT E134990 T1 ATE134990 T1 AT E134990T1 AT 91917624 T AT91917624 T AT 91917624T AT 91917624 T AT91917624 T AT 91917624T AT E134990 T1 ATE134990 T1 AT E134990T1
Authority
AT
Austria
Prior art keywords
related compounds
formoterol
new method
preparing
preparing formoterol
Prior art date
Application number
AT91917624T
Other languages
English (en)
Inventor
Jan William Trofast
Edib Jakupovic
Lena Katarina Mansson
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Application granted granted Critical
Publication of ATE134990T1 publication Critical patent/ATE134990T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/42—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C07C233/43—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of a saturated carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/14—Preparation of carboxylic acid amides by formation of carboxamide groups together with reactions not involving the carboxamide groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Pyrrole Compounds (AREA)
AT91917624T 1990-09-26 1991-09-25 Neues verfahren zur darstellung von formoterol und vewandten verbindungen ATE134990T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9003057A SE9003057D0 (sv) 1990-09-26 1990-09-26 New process

Publications (1)

Publication Number Publication Date
ATE134990T1 true ATE134990T1 (de) 1996-03-15

Family

ID=20380456

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91917624T ATE134990T1 (de) 1990-09-26 1991-09-25 Neues verfahren zur darstellung von formoterol und vewandten verbindungen

Country Status (28)

Country Link
EP (1) EP0550612B1 (de)
JP (1) JP2801401B2 (de)
KR (1) KR0179639B1 (de)
AT (1) ATE134990T1 (de)
AU (1) AU652386B2 (de)
BG (1) BG61605B1 (de)
CA (1) CA2091343C (de)
CZ (1) CZ284256B6 (de)
DE (1) DE69117768T2 (de)
DK (1) DK0550612T3 (de)
EE (1) EE02979B1 (de)
ES (1) ES2084831T3 (de)
FI (1) FI111714B (de)
GR (1) GR3020134T3 (de)
HK (1) HK52297A (de)
HU (1) HU214054B (de)
IE (1) IE74387B1 (de)
IS (1) IS1684B (de)
LT (1) LT3813B (de)
LV (1) LV10770B (de)
NO (1) NO301709B1 (de)
PL (1) PL166434B1 (de)
PT (1) PT99051B (de)
RU (1) RU2079486C1 (de)
SE (1) SE9003057D0 (de)
SG (1) SG43150A1 (de)
SK (1) SK22793A3 (de)
WO (1) WO1992005147A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6299863B1 (en) 1992-04-03 2001-10-09 Sepracor Inc. Aerosol formulations containing micronized optically pure (R,R) formoterol for bronchodilating therapy
US6866839B2 (en) 1991-04-05 2005-03-15 Sepracor Inc. Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
US5795564A (en) * 1991-04-05 1998-08-18 Sepracor, Inc. Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
US5629200A (en) 1993-11-18 1997-05-13 Daicel Chemical Industries, Ltd. Production of optically active 2-amino-1-phenylethanol derivatives by asymetrical assimilation
SE9404080L (sv) * 1993-12-28 1995-06-29 Ciba Geigy Ag Förfarande för framställning av en optiskt ren enantiomer av formoterol
US6040344A (en) * 1996-11-11 2000-03-21 Sepracor Inc. Formoterol process
ES2178015T3 (es) * 1996-11-11 2002-12-16 Sepracor Inc Procedimiento de preparacion de isomeros de formoterol opticamente puros.
US6303145B2 (en) 1999-05-10 2001-10-16 Sepracor Inc. (S,R) formoterol methods and compositions
AR028948A1 (es) 2000-06-20 2003-05-28 Astrazeneca Ab Compuestos novedosos
WO2002066021A2 (de) * 2001-02-22 2002-08-29 Universitätsklinikum Charite Medizinische Fakultät Der Humboldt-Universität Zu Berlin Inhibitoren der protein kinase d und der protein kinase 2 als mittel zur hemmung von tumorzellen und zur stimulierung der angiogehese
US6472563B1 (en) 2001-11-09 2002-10-29 Sepracor Inc. Formoterol tartrate process and polymorph
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
TW200738634A (en) 2005-08-02 2007-10-16 Astrazeneca Ab New salt
WO2008035380A2 (en) * 2006-09-19 2008-03-27 Natco Pharma Limited An improved process for the preparation of high purity formoterol and its pharmaceutically acceptable salts
TW200825084A (en) 2006-11-14 2008-06-16 Astrazeneca Ab New compounds 521
AU2008320590A1 (en) * 2007-10-29 2009-05-07 Generics [Uk] Limited Novel chromatography methods
BRPI0822693A2 (pt) 2008-05-13 2015-07-07 Astrazeneca Ab Derivados de quinuclidina como antagonistas do receptor muscarínico m3
CN101921200B (zh) * 2009-06-16 2014-01-15 上海医药工业研究院 一种n-苄基-1-(4-甲氧基苯基)-2-丙胺的制备方法
WO2011061527A1 (en) 2009-11-17 2011-05-26 Astrazeneca Ab Combinations comprising a glucocorticoid receptor modulator for the treatment of respiratory diseases
CN115368250A (zh) * 2022-09-02 2022-11-22 博诺康源(北京)药业科技有限公司 拆分福莫特罗手性中间体的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2305092A1 (de) 1972-02-05 1973-08-16 Yamanouchi Pharma Co Ltd Alpha-aminomethylbenzylalkoholderivate
GB1468156A (en) * 1973-07-19 1977-03-23 Ici Ltd Phenylethylamine derivatives
JPS643121A (en) 1987-06-25 1989-01-06 Mitsubishi Kasei Corp Remedy for endometriosis
ES2005492A6 (es) 1987-12-23 1989-03-01 Lasa Lab Procedimiento de obtencion de n-(2-hidroxi-5-(1-hidroxi-2((2- (4-metoxifenil)-1metiletil)amino)etil)fenil)foramida (i).

Also Published As

Publication number Publication date
FI931333A0 (fi) 1993-03-25
EE02979B1 (et) 1997-04-15
WO1992005147A1 (en) 1992-04-02
EP0550612A1 (de) 1993-07-14
CZ44293A3 (en) 1994-01-19
PT99051A (pt) 1992-08-31
IE74387B1 (en) 1997-07-30
NO931058L (no) 1993-03-23
IS3756A7 (is) 1992-03-27
LT3813B (en) 1996-03-25
CZ284256B6 (cs) 1998-10-14
CA2091343A1 (en) 1992-03-27
GR3020134T3 (en) 1996-08-31
SK22793A3 (en) 1993-07-07
CA2091343C (en) 2002-07-09
SE9003057D0 (sv) 1990-09-26
PT99051B (pt) 1999-02-26
FI111714B (fi) 2003-09-15
RU2079486C1 (ru) 1997-05-20
DE69117768T2 (de) 1996-08-29
EP0550612B1 (de) 1996-03-06
NO301709B1 (no) 1997-12-01
LTIP1715A (en) 1995-07-25
HK52297A (en) 1997-05-02
FI931333A (fi) 1993-04-22
KR0179639B1 (ko) 1999-05-15
HU214054B (en) 1997-12-29
AU8652091A (en) 1992-04-15
ES2084831T3 (es) 1996-05-16
JP2801401B2 (ja) 1998-09-21
IS1684B (is) 1998-02-24
JPH06501262A (ja) 1994-02-10
NO931058D0 (no) 1993-03-23
HUT65912A (en) 1994-07-28
AU652386B2 (en) 1994-08-25
DK0550612T3 (da) 1996-07-22
SG43150A1 (en) 1997-10-17
LV10770B (en) 1996-04-20
HU9300867D0 (en) 1993-06-28
BG61605B1 (bg) 1998-01-30
PL166434B1 (pl) 1995-05-31
IE913373A1 (en) 1992-04-08
LV10770A (lv) 1995-08-20
BG97576A (bg) 1994-03-31
DE69117768D1 (de) 1996-04-11

Similar Documents

Publication Publication Date Title
ATE134990T1 (de) Neues verfahren zur darstellung von formoterol und vewandten verbindungen
DE69331207D1 (de) Verfahren zur Behandlung eines resorbierbaren Implantationsmaterials
AT386201B (de) Verfahren zum herstellen neuer n-imidazolylderivate von bicyclischen verbindungen und ihren pharmazeutisch annehmbaren salzen
DE69102552T2 (de) Verfahren zur Behandlung von Fasermaterialien.
DE59106370D1 (de) Verfahren zum Herstellen von Zementklinker.
DE69730787D1 (de) Verfahren zur Herstellung von PTH- und PTrP-analogen Verbindungen
DE69303497T2 (de) Pyrrolidinderivate und Verfahren zur Herstellung solcher Verbindungen
ATA243893A (de) Maschinenanlage zur behandlung der schotterbettung eines gleises
DE69805305D1 (de) Verwendung von phanquinon zur behandlung von alzheimer's krankheit
DE59105224D1 (de) Verfahren zur Herstellung von N-substituierten Pyrrolidonen.
DE59306642D1 (de) Verfahren zur Herstellung von Calcium-L-ascorbat-2-phosphat
DE69202619D1 (de) Integriertes kontinuierliches Verfahren zum Herstellen von Dimethylcarbonat und Methyl-Tertbutyläther.
DE59107293D1 (de) Verfahren zur Herstellung von N-substituierten Imidazolen
ATA206691A (de) Verfahren zur herstellung von 8-chlorochinolonderivaten
DE69118001D1 (de) Verfahren zur Herstellung von beta-Lactamderivaten
DE69107224T2 (de) Verfahren zur Desilylierung eines 4-Silyloxy-tetrahydro-pyran-2-ones.
DE69131093T2 (de) Bipolartransistor und Verfahren zu dessen Herstellung
DE59106854D1 (de) Verfahren zur Herstellung von N-(2-Chlor-pyridin-5-yl-methyl)-ethylendiamin.
DE59205760D1 (de) Verfahren zur Herstellung N-substituierter Nitro-p-phenylendiamine
DE59509391D1 (de) Verfahren zur Herstellung von N-(4-Fluor-phenyl)-N-isopropyl-chloracetamid
DE59203348D1 (de) Verfahren zur Herstellung eines Knochenimplantates.
ATA290283A (de) Verfahren zur herstellung von piperazinylbenzoheterozyklischen verbindungen und ihren pharmazeutisch annehmbaren salzen

Legal Events

Date Code Title Description
EELA Cancelled due to lapse of time